Loading...

ELITE PHARMACEUTICALS INC Investor Conferences 8-K Filing

LT P

ELITE PHARMACEUTICALS INC

()

2026 8-K

Product Launch Announcement

Financial Results Report

Conference Call Announcement

Quarterly Financial Report

Conference Call Update

FDA Approval Granted

Conference Call Announcement

Quarterly Results Update

Financial Statements

Clinical Trials

New Product Launches

Product Shipment

Quarterly Results

External Links:

On February 11, 2026, Elite Pharmaceuticals, Inc. announced a conference call scheduled for February 18, 2026, to discuss its financial results for Q3 of fiscal year 2026 ending December 31, 2025.

AI Assistant

ELITE PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.